Fumery M, Defrance A, Roblin X, Altwegg R, et al. Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study. Aliment Pharmacol Ther 2022 Dec 19. doi: 10.1111/apt.17358.
PMID: 36534763